Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
275 studies found for:    Recruiting | NIDDK
Show Display Options
Rank Status Study
1 Recruiting Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Prospective Observational Cohort Study Protocol
Condition: Lower Urinary Tract Symptoms
Interventions: Other: None-observational;   Procedure: Magnetic Resonance Imaging (MRI);   Other: Multimodal Automated Sensory Testing System;   Other: Auditory Sensitivity Test
2 Recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
3 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
4 Recruiting Gastroparesis Registry 2
Conditions: Gastroparesis;   Diabetic Gastroparesis;   Idiopathic Gastroparesis
Intervention:
5 Recruiting Longitudinal Study of Mitochondrial Hepatopathies
Conditions: Acute Liver Failure;   Mitochondrial Diseases;   End Stage Liver Disease;   Respiratory Chain Deficiencies, Mitochondrial;   Disorder of Fatty Acid Oxidation
Intervention:
6 Recruiting NAFLD Pediatric Database 2
Condition: Liver Disease
Intervention:
7 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
8 Recruiting Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Condition: Liver Disease
Intervention:
9 Recruiting Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)
Conditions: Liver Diseases;   Alagille Syndrome;   Alpha 1-Antitrypsin Deficiency
Intervention:
10 Recruiting Biliary Atresia Study in Infants and Children
Condition: Biliary Atresia
Intervention:
11 Recruiting Familial Barrett's Esophagus
Conditions: Barrett's Esophagus;   Esophageal Neoplasm
Intervention:
12 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
Intervention:
13 Recruiting Low-Dose Leptin and the Formerly-Obese
Condition: Obesity
Interventions: Drug: Leptin;   Behavioral: Dietary modification;   Drug: T3 repletion
14 Recruiting Biliary Atresia Research Consortium
Conditions: Biliary Atresia;   Cholestasis
Intervention:
15 Recruiting Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta 3-Adrenergic Receptor Agonists
Condition: Healthy Volunteers
Interventions: Drug: Mirabegron;   Other: Placebo
16 Recruiting Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Drug: Metformin and Liraglutide
17 Recruiting Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
Condition: Lipodystrophy
Interventions: Drug: ISIS 304801;   Drug: Placebo
18 Recruiting A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
Condition: Kidney Disease
Intervention: Drug: N-acetyl-mannosamine (ManNAc)
19 Recruiting Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Conditions: Liver Disease;   Fatty Liver
Intervention:
20 Recruiting Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
Condition: Chronic Hepatitis C
Interventions: Drug: Sofosbuvir;   Drug: GS-5816

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.